United Kingdom Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD08504
Publication Date March 2009
Publisher Global Markets Direct
Product Type Report
Pages 112
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

United Kingdom Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the UK diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in UK

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Diabetic Care Devices
    • 3.2 Glucose Monitoring Devices
      • 3.2.1 Blood Glucose Meters
        • 3.2.1.1 Traditional Glucose Meters
        • 3.2.1.2 Continous Glucose Monitoring Systems
      • 3.2.2 Blood Glucose Strips
    • 3.3 Insulin Delivery
      • 3.3.1 InsulinPens
        • 3.3.1.1 Reusable Insulin Pens
        • 3.3.1.2 Disposable Insulin Pens
      • 3.3.2 Insulin Syringes
      • 3.3.3 Insulin Pumps
        • 3.3.3.1 Traditional Insulin Pumps
        • 3.3.3.2 Disposable Insulin Pumps
      • 3.3.4 Traditional Insulin Pump Accessories
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
    • 4.4 United Kingdom Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of Medical Devices
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
        • 5.1.2.4 Class III devices
    • 5.2 Medical Device approval fee
    • 5.3 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Government Policies for Reimbursement
  • 7 Distribution Structure
  • 8 Diabetes Care Devices In United Kingdom
    • 8.1 Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • 8.3 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015
    • 8.4 Diabetes Care Devices, United Kingdom, Company Share (2006-2007)
  • 9 Glucose Monitoring In United Kingdom
    • 9.1 Glucose Monitoring Overall Revenue (2000-2015)
      • 9.1.1 Blood Glucose Meters Revenue (2000-2015)
    • 9.2 Glucose Monitoring Overall Volume (2000-2015)
      • 9.2.1 Blood Glucose Meters Volume (2000-2015)
    • 9.3 Glucose Monitoring Average Price (2000-2015)
    • 9.4 Glucose Monitoring Distribution Share (2007-2008)
    • 9.5 Glucose Monitoring, United Kingdom, Company Share (2006-2007)
  • 10 Insulin Delivery In United Kingdom
    • 10.1 Insulin Delivery Overall Revenue (2000-2015)
      • 10.1.1 Insulin Pens Revenue (2000-2015)
      • 10.1.2 Insulin Pumps (Traditional Insulin Pumps) Revenue (2000-2015)
    • 10.2 Insulin Delivery Overall Volume (2000-2015)
      • 10.2.1 Insulin Pens Volume (2000-2015)
      • 10.2.2 Insulin Pumps (Traditional Insulin Pumps) Volume (2000-2015)
    • 10.3 Insulin Delivery Average Price (2000-2015)
    • 10.4 Insulin Delivery Distribution Share (2007-2008)
    • 10.5 Insulin Delivery, United Kingdom, Company Share (2006-2007)
  • 11 Overview of Key Companies in United Kingdom Diabetes Care Devices Market
    • 11.1 F. Hoffmann-La Roche Ltd. Company Profile
      • 11.1.1 Company Overview
      • 11.1.2 Value Chain Analysis
        • 11.1.2.1 Manufacturing
        • 11.1.2.2 Product Development
        • 11.1.2.3 Sales and Marketing
      • 11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
        • 11.1.3.1 F. Hoffmann-La Roche Ltd Pipeline Products By Equipment Type
        • 11.1.3.2 F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage
        • 11.1.3.3 F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area
    • 11.2 LifeScan, Inc. Company Profile
      • 11.2.1 Company Overview
      • 11.2.2 LifeScan, Inc. Pipeline Products
        • 11.2.2.1 LifeScan, Inc. Pipeline Products By Equipment Type
        • 11.2.2.2 LifeScan, Inc. Pipeline Products By Development Stage
        • 11.2.2.3 LifeScan, Inc. Pipeline Products By Therapy Area
        • 11.2.2.4 LifeScan, Inc. Pipeline Products By Clinical Trials
        • 11.2.2.5 LifeScan, Inc. Pipeline Products By News Summary
    • 11.3 Bayer HealthCare AG Company Profile
      • 11.3.1 Company Overview
      • 11.3.2 Value Chain Analysis
        • 11.3.2.1 Manufacturing
        • 11.3.2.2 Product Development
        • 11.3.2.3 Sales and Marketing
      • 11.3.3 Bayer HealthCare AG Pipeline Products
        • 11.3.3.1 Bayer HealthCare AG Pipeline Products By Equipment Type
        • 11.3.3.2 Bayer HealthCare AG Pipeline Products By Development Stage
        • 11.3.3.3 Bayer HealthCare AG Pipeline Products By Therapy Area
        • 11.3.3.4 Bayer HealthCare AG Pipeline Products By News Summary
    • 11.4 Novo Nordisk A/S Company Profile
      • 11.4.1 Company Overview
      • 11.4.2 Novo Nordisk A/S Pipeline Products
        • 11.4.2.1 Novo Nordisk A/S Pipeline Products by Equipment Type
        • 11.4.2.2 Novo Nordisk A/S Pipeline Products by Development Stage
        • 11.4.2.3 Novo Nordisk A/S Pipeline Products By Therapy Area
        • 11.4.2.4 Novo Nordisk A/S Pipeline Products By Clinical Trials
    • 11.5 Abbott Laboratories Company Profile
      • 11.5.1 Company Overview
      • 11.5.2 Value Chain Analysis
        • 11.5.2.1 Manufacturing
        • 11.5.2.2 Product Development
        • 11.5.2.3 Sales and Marketing
      • 11.5.3 Abbott Laboratories Pipeline Products
        • 11.5.3.1 Abbott Laboratories Pipeline Products By Equipment Type
        • 11.5.3.2 Abbott Laboratories Pipeline Products By Development Stage
        • 11.5.3.3 Abbott Laboratories Pipeline Products By Therapy Area
        • 11.5.3.4 Abbott Laboratories Pipeline Products By Clinical Trials
        • 11.5.3.5 Abbott Laboratories Pipeline Products By News Summary
    • 11.6 Eli Lilly and Company Company Profile
      • 11.6.1 Company Overview
      • 11.6.2 Value Chain Analysis
        • 11.6.2.1 Manufacturing
        • 11.6.2.2 Product Development
        • 11.6.2.3 Sales and Marketing
      • 11.6.3 Eli Lilly and Company Pipeline Products
        • 11.6.3.1 Eli Lilly and Company Pipeline Products by Equipment Type
        • 11.6.3.2 Eli Lilly and Company Pipeline Products by Development Stage
        • 11.6.3.3 Eli Lilly and Company Pipeline Products by Therapy Area
        • 11.6.3.4 Eli Lilly and Company Pipeline Products by Clinical Trials
        • 11.6.3.5 Eli Lilly and Company Pipeline Products by News Summary
    • 11.7 Becton, Dickinson and Company Profile
      • 11.7.1 Company Overview
      • 11.7.2 Value Chain Analysis
        • 11.7.2.1 Manufacturing
        • 11.7.2.2 Product Development
        • 11.7.2.3 Sales and Marketing
    • 11.8 Medtronic, Inc. Company Profile
      • 11.8.1 Company Overview
      • 11.8.2 Value Chain Analysis
        • 11.8.2.1 Manufacturing
        • 11.8.2.2 Product Development
        • 11.8.2.3 Sales and Marketing
      • 11.8.3 Medtronic, Inc. Pipeline Products
        • 11.8.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
        • 11.8.3.2 Medtronic, Inc. Pipeline Products By Development Stage
        • 11.8.3.3 Medtronic, Inc. Pipeline Products By Therapy Area
        • 11.8.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials
        • 11.8.3.5 Medtronic, Inc. Pipeline Products By News Summary
    • 11.9 Smiths Medical Company Profile
      • 11.9.1 Company Overview
      • 11.9.2 Value Chain Analysis
        • 11.9.2.1 Manufacturing
        • 11.9.2.2 Product Development
        • 11.9.2.3 Sales and Marketing
  • 12 Appendix
    • 12.1 Global Markets Direct Research Methodology
    • 12.2 Coverage
    • 12.3 Secondary Research
    • 12.4 Primary Research
    • 12.5 Models
    • 12.6 Forecasts
    • 12.7 Expert Panel Validation
    • 12.8 Currency Conversion
    • 12.9 Contact Us
    • 12.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: United Kingdom Healthcare Trade Statistics, 2001-2006
    • Table 3: Medical Device Approval Fee in UK, 2006
    • Table 4: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 5: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Table 6: Diabetes Care Devices, United Kingdom, Cross-Category Analysis, 2000-2015
    • Table 7: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 8: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 9: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015
    • Table 10: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2008
    • Table 11: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2008-2015
    • Table 12: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 13: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 14: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 15: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 16: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 17: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 18: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 19: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 20: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 21: Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 22: Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 23: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 24: Glucose Monitoring, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 25: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 26: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 27: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 28: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 29: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Revenue ($ mn), Historic, 2000-2008
    • Table 30: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Table 31: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Table 32: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 33: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 34: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 35: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Volume (Units), Historic, 2000-2008
    • Table 36: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Volume (Units), Forecast, 2008-2015
    • Table 37: Insulin Delivery, United Kingdom, Average Price ($), Historic, 2000-2008
    • Table 38: Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2008-2015
    • Table 39: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 40: Insulin Delivery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type
    • Table 42: F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage
    • Table 43: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area
    • Table 44: LifeScan, Inc. Pipeline Products by Equipment Type
    • Table 45: LifeScan, Inc. Pipeline Products By Development Stage
    • Table 46: LifeScan, Inc. Pipeline Products By Therapy Area
    • Table 47: LifeScan, Inc. Pipeline Products By Clinical Trials
    • Table 48: LifeScan, Inc. Pipeline Products By News Summary
    • Table 49: Bayer HealthCare AG Pipeline Products by Equipment Type
    • Table 50: Bayer HealthCare AG Pipeline Products By Development Stage
    • Table 51: Bayer HealthCare AG Pipeline Products By Therapy Area
    • Table 52: Bayer HealthCare AG Pipeline Products By News Summary
    • Table 53: Novo Nordisk A/S Pipeline Products by Equipment Type
    • Table 54: Novo Nordisk A/S Pipeline Products By Development Stage
    • Table 55: Novo Nordisk A/S Pipeline Products By Therapy Area
    • Table 56: Novo Nordisk A/S Pipeline Products By Clinical Trials
    • Table 57: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 58: Abbott Laboratories Pipeline Products By Development Stage
    • Table 59: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 60: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 61: Abbott Laboratories Pipeline Products By News Summary
    • Table 62: Eli Lilly and Company Pipeline Products by Equipment Type
    • Table 63: Eli Lilly and Company Pipeline Products by Development Stage
    • Table 64: Eli Lilly and Company Pipeline Products by Therapy Area
    • Table 65: Eli Lilly and Company Pipeline Products by Clinical Trials
    • Table 66: Eli Lilly and Company Pipeline Products by News Summary
    • Table 67: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 68: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 69: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 70: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 71: Medtronic, Inc. Pipeline Products By News Summary
    • Table 72: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 7: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 8: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 14: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 15: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Figure 16: Diabetes Care Devices, United Kingdom, Cross-Category Analysis, 2000-2015
    • Figure 17: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 19: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015
    • Figure 20: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2000-2008
    • Figure 21: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2008-2015
    • Figure 22: Diabetes Care Devices, United Kingdom, Company Share (%), 2007
    • Figure 23: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 24: Glucose Monitoring, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 25: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 26: Blood Glucose Meters, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 27: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 28: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 29: Glucose Monitoring, United Kingdom, Company Share (%), 2007
    • Figure 30: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 31: Insulin Delivery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 32: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 33: Insulin Pens, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 34: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Revenue ($ mn) Historic, 2000-2008
    • Figure 35: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Revenue ($ mn), Forecast, 2008-2015
    • Figure 36: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 37: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 38: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Volume (Units), Historic, 2000-2008
    • Figure 39: Insulin Pumps (Traditional Insulin Pumps), United Kingdom, Volume (Units), Forecast, 2008-2015
    • Figure 40: Insulin Delivery, United Kingdom, Company Share (%), 2007
    • Figure 41: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 42: Bayer HealthCare AG Value Chain Analysis
    • Figure 43: Abbott Laboratories Value Chain Analysis
    • Figure 44: Eli Lilly and Company Value Chain Analysis
    • Figure 45: Becton, Dickinson and Company Value Chain Analysis
    • Figure 46: Medtronic, Inc. Value Chain Analysis
    • Figure 47: Smiths Medical Value Chain Analysis
    • Figure 48: Global Markets Direct Methodology